ES2037418T3 - Agentes diureticos de glutaramida enantiomerica. - Google Patents

Agentes diureticos de glutaramida enantiomerica.

Info

Publication number
ES2037418T3
ES2037418T3 ES198989304698T ES89304698T ES2037418T3 ES 2037418 T3 ES2037418 T3 ES 2037418T3 ES 198989304698 T ES198989304698 T ES 198989304698T ES 89304698 T ES89304698 T ES 89304698T ES 2037418 T3 ES2037418 T3 ES 2037418T3
Authority
ES
Spain
Prior art keywords
enantiomerica
dianetic
glutaramide
agents
enanciomero
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198989304698T
Other languages
English (en)
Spanish (es)
Inventor
John Christopher Dr. Danilewicz
Michael Trevelyan Dr. Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of ES2037418T3 publication Critical patent/ES2037418T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Detergent Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Cosmetics (AREA)
ES198989304698T 1988-05-19 1989-05-09 Agentes diureticos de glutaramida enantiomerica. Expired - Lifetime ES2037418T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888811873A GB8811873D0 (en) 1988-05-19 1988-05-19 Therapeutic agents

Publications (1)

Publication Number Publication Date
ES2037418T3 true ES2037418T3 (es) 1993-06-16

Family

ID=10637176

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198989304698T Expired - Lifetime ES2037418T3 (es) 1988-05-19 1989-05-09 Agentes diureticos de glutaramida enantiomerica.

Country Status (29)

Country Link
EP (1) EP0342850B1 (enExample)
JP (1) JPH072699B2 (enExample)
KR (1) KR920000561B1 (enExample)
CN (1) CN1015361B (enExample)
AT (1) ATE76399T1 (enExample)
AU (1) AU602813B2 (enExample)
CA (1) CA1331197C (enExample)
CS (1) CS274502B2 (enExample)
DD (1) DD283772A5 (enExample)
DE (1) DE68901582D1 (enExample)
DK (1) DK172032B1 (enExample)
EG (1) EG19007A (enExample)
ES (1) ES2037418T3 (enExample)
FI (1) FI93541C (enExample)
GB (1) GB8811873D0 (enExample)
GR (1) GR3004968T3 (enExample)
HU (1) HU205067B (enExample)
IE (1) IE60724B1 (enExample)
IL (1) IL90267A (enExample)
MX (1) MX16067A (enExample)
MY (1) MY104735A (enExample)
NO (1) NO173647C (enExample)
NZ (1) NZ229186A (enExample)
PH (1) PH26740A (enExample)
PL (1) PL154813B1 (enExample)
PT (1) PT90584B (enExample)
SU (1) SU1766251A3 (enExample)
YU (1) YU47973B (enExample)
ZA (1) ZA893696B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8812597D0 (en) * 1988-05-27 1988-06-29 Pfizer Ltd Therapeutic agents
GB8820844D0 (en) * 1988-09-05 1988-10-05 Pfizer Ltd Therapeutic agents
GB9000725D0 (en) * 1990-01-12 1990-03-14 Pfizer Ltd Therapeutic agents
ATE130292T1 (de) * 1993-09-22 1995-12-15 Pfizer Res & Dev Hydrierung.
US7468390B2 (en) 2002-01-17 2008-12-23 Novartis Ag Methods of treatment and pharmaceutical composition
AR057882A1 (es) 2005-11-09 2007-12-26 Novartis Ag Compuestos de accion doble de bloqueadores del receptor de angiotensina e inhibidores de endopeptidasa neutra
US8993631B2 (en) 2010-11-16 2015-03-31 Novartis Ag Method of treating contrast-induced nephropathy
RU2667643C2 (ru) 2012-08-24 2018-09-21 Новартис Аг Ингибиторы nep для лечения заболеваний, характеризующихся увеличением или ремоделированием предсердия
WO2017033128A1 (en) 2015-08-25 2017-03-02 Novartis Ag Biphenyl-substitued 4-amino-butyric acid derivatives and their use in the synthesis of nep inhibitors
US20180311241A1 (en) 2015-10-29 2018-11-01 Cadila Healthcare Limited Pharmaceutical synergistic combination

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR880007441A (ko) * 1986-12-11 1988-08-27 알렌 제이.스피겔 스피로-치환된 글루타르아미드 이뇨제

Also Published As

Publication number Publication date
DE68901582D1 (de) 1992-06-25
JPH0222256A (ja) 1990-01-25
CA1331197C (en) 1994-08-02
MX16067A (es) 1993-10-01
ZA893696B (en) 1990-12-28
GB8811873D0 (en) 1988-06-22
EG19007A (en) 1994-11-30
DD283772A5 (de) 1990-10-24
IE60724B1 (en) 1994-08-10
SU1766251A3 (ru) 1992-09-30
JPH072699B2 (ja) 1995-01-18
HUT53596A (en) 1990-11-28
PT90584B (pt) 1994-09-30
PL279491A1 (en) 1989-11-27
FI93541B (fi) 1995-01-13
KR920000561B1 (ko) 1992-01-16
NZ229186A (en) 1990-10-26
CN1015361B (zh) 1992-02-05
IL90267A (en) 1993-08-18
ATE76399T1 (de) 1992-06-15
HU205067B (en) 1992-03-30
AU602813B2 (en) 1990-10-25
IL90267A0 (en) 1989-12-15
MY104735A (en) 1994-05-31
CS274502B2 (en) 1991-04-11
PL154813B1 (en) 1991-09-30
FI93541C (fi) 1995-04-25
AU3490489A (en) 1989-11-23
KR900017993A (ko) 1990-12-20
IE891613L (en) 1989-11-19
FI892386A0 (fi) 1989-05-18
NO892002L (no) 1989-11-20
NO892002D0 (no) 1989-05-18
PH26740A (en) 1992-09-28
NO173647B (no) 1993-10-04
EP0342850A1 (en) 1989-11-23
FI892386L (fi) 1989-11-20
DK172032B1 (da) 1997-09-22
GR3004968T3 (enExample) 1993-04-28
EP0342850B1 (en) 1992-05-20
CS296589A2 (en) 1990-09-12
DK240889D0 (da) 1989-05-18
CN1037704A (zh) 1989-12-06
DK240889A (da) 1989-11-20
PT90584A (pt) 1989-11-30
YU102289A (en) 1991-06-30
YU47973B (sh) 1996-08-13
NO173647C (no) 1994-01-12

Similar Documents

Publication Publication Date Title
DE3880047D1 (de) Zusammensetzung eines zusatzes.
DE3889624D1 (de) Blockierung von Polydienen.
BE865150A (fr) Base d'ancrage
ES2066991T3 (es) Agentes hipoglucemiantes de oxazolidinadiona.
MX9205305A (es) Procedimiento para la preparacion de derivados de clorosulfato y sulfamato de 2,3:4,5-bis-o-(1-metiletiliden)-b-d-fructopiranosa y (1-metilciclohexil)metanol
FI872917A0 (fi) Farmaceutiska baerare, vilka frigoer aktivaemnet reglerbart.
DE3879806D1 (de) Polymerisierung von aethylen.
AR246509A1 (es) Una cetimina, su preparacion y un agente de entrecruzamiento que la contiene.
IT1157072B (it) Macchina circolare per maglieria e procedimento per la fabbricazione di felpa in maglieria operata
ES2061695T3 (es) Acidos quinolinacarboxilicos sustituidos con heterociclos.
DE69006854D1 (de) Anhaftende selbstverkapselnde spritzzusammensetzungen von bioregulatorischen agenzien.
TR23424A (tr) 1,2,3,6-tetrahidro-5-nitro-pirimidin tuerevleri
IT8720200A0 (it) Agenti stabilizzanti costituiti da 1,3,2-ossazafosfolidine.
DE3851599D1 (de) Flammfeste Mischungen von Polyäthermimid-Siloxan-Polyätherimid-Copolymer.
ES2013796A6 (es) Agente cosmetico a base de derivados de pirimidina y retinoides, y procedimiento para prepararlo.
ES2038127T3 (es) Procedimiento para preparar monosulfactamas.
JPS5240682A (en) Method of dyeing or printing fiber base
DE3750344D1 (de) Beschleuniger der Aktivität von Hydrolase.
BE872914A (fr) Derives de types n-acyl-2', n-alkyl-2', n,n-diacyl-4,2', n,n-dialkyl-4,2',n-acyl-4 n-alkyl-2' et n-alkyl-4 n-acyl-2' fortimicine b
FR2308498A1 (fr) Elements tels que baignoires et analogues, presentant l'aspect du marbre
IT7830928A0 (it) Apparecchiatura per la decorazione di tessuti e relativo procedimento.
DE3770206D1 (de) Schnellnachweis von n.-gonorrhoe ohne kultur.
DE69002136D1 (de) Saccharidderivate von protocatechualdehyd.
MX9204642A (es) 1,4-dihidropiridinas con actividad paf-antagonista
DE68905075D1 (de) Herstellung von tris(2-zyanaethyl)amin.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 342850

Country of ref document: ES